NO20005766L - Benzamidderivater for behandling av sykdommer mediert av cytokiner - Google Patents
Benzamidderivater for behandling av sykdommer mediert av cytokinerInfo
- Publication number
- NO20005766L NO20005766L NO20005766A NO20005766A NO20005766L NO 20005766 L NO20005766 L NO 20005766L NO 20005766 A NO20005766 A NO 20005766A NO 20005766 A NO20005766 A NO 20005766A NO 20005766 L NO20005766 L NO 20005766L
- Authority
- NO
- Norway
- Prior art keywords
- cytokines
- treatment
- diseases mediated
- benzamide derivatives
- 6alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/56—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9810356.7A GB9810356D0 (en) | 1998-05-15 | 1998-05-15 | Amide derivatives |
GBGB9905970.1A GB9905970D0 (en) | 1999-03-17 | 1999-03-17 | Amide derivatives |
PCT/GB1999/001491 WO1999059960A1 (en) | 1998-05-15 | 1999-05-11 | Benzamide derivatives for the treatment of diseases mediated by cytokines |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20005766D0 NO20005766D0 (no) | 2000-11-14 |
NO20005766L true NO20005766L (no) | 2001-01-12 |
Family
ID=26313677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20005766A NO20005766L (no) | 1998-05-15 | 2000-11-14 | Benzamidderivater for behandling av sykdommer mediert av cytokiner |
Country Status (23)
Country | Link |
---|---|
US (1) | US6465455B1 (de) |
EP (1) | EP1077930B1 (de) |
JP (1) | JP2003505337A (de) |
KR (1) | KR100628284B1 (de) |
CN (1) | CN1188389C (de) |
AT (1) | ATE282023T1 (de) |
AU (1) | AU748397B2 (de) |
BR (1) | BR9910467A (de) |
CA (1) | CA2328699A1 (de) |
DE (1) | DE69921804T2 (de) |
ES (1) | ES2230853T3 (de) |
HK (1) | HK1033753A1 (de) |
HU (1) | HUP0102367A3 (de) |
ID (1) | ID27285A (de) |
IL (1) | IL139710A (de) |
NO (1) | NO20005766L (de) |
NZ (1) | NZ507143A (de) |
PL (1) | PL197181B1 (de) |
PT (1) | PT1077930E (de) |
RU (1) | RU2205823C2 (de) |
SK (1) | SK286247B6 (de) |
TR (1) | TR200003355T2 (de) |
WO (1) | WO1999059960A1 (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7772432B2 (en) | 1991-09-19 | 2010-08-10 | Astrazeneca Ab | Amidobenzamide derivatives which are useful as cytokine inhibitors |
GB9816837D0 (en) | 1998-08-04 | 1998-09-30 | Zeneca Ltd | Amide derivatives |
IL134723A0 (en) | 1997-09-23 | 2001-04-30 | Zeneca Ltd | Amide derivatives for the treatment of diseases mediated by cytokines |
NZ507144A (en) | 1998-05-15 | 2002-10-25 | Astrazeneca Ab | Benzamide derivatives useful for the treatment of diseases mediated by cytokines |
PL197181B1 (pl) | 1998-05-15 | 2008-03-31 | Astrazeneca Ab | Pochodna benzamidowa, sposób jej wytwarzania, jej kompozycja farmaceutyczna i jej zastosowanie do wytwarzania leku |
EP1102750A1 (de) | 1998-08-04 | 2001-05-30 | AstraZeneca AB | Amid-derivate verwendbar als inhibitoren der cytokinproduktion |
WO2000010563A1 (en) | 1998-08-20 | 2000-03-02 | Smithkline Beecham Corporation | Novel substituted triazole compounds |
RU2219171C2 (ru) | 1998-09-25 | 2003-12-20 | Астразенека Аб | Производные амида, способ их получения и фармацевтическая композиция на их основе |
IL145357A0 (en) | 1999-03-17 | 2002-06-30 | Astrazeneca Ab | Amide derivatives |
WO2000055120A1 (en) * | 1999-03-17 | 2000-09-21 | Astrazeneca Ab | Amide derivatives |
GB9906566D0 (en) | 1999-03-23 | 1999-05-19 | Zeneca Ltd | Chemical compounds |
GB9924092D0 (en) | 1999-10-13 | 1999-12-15 | Zeneca Ltd | Pyrimidine derivatives |
AU1781601A (en) | 1999-11-23 | 2001-06-04 | Smithkline Beecham Corporation | 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
US6943161B2 (en) | 1999-12-28 | 2005-09-13 | Pharmacopela Drug Discovery, Inc. | Pyrimidine and triazine kinase inhibitors |
WO2002049632A1 (fr) * | 2000-12-18 | 2002-06-27 | Institute Of Medicinal Molecular Design. Inc. | Inhibiteurs de production et de liberation de cytokines inflammatoires |
CA2439410C (en) | 2001-02-27 | 2011-09-06 | William D. Figg | Analogs of thalidomide as potential angiogenesis inhibitors |
AU2003242098B2 (en) * | 2002-06-10 | 2008-11-20 | Institute Of Medicinal Molecular Design, Inc | Inhibitors against activation of NFkappaB |
AU2003281198A1 (en) * | 2002-07-04 | 2004-01-23 | Mitsui Chemicals, Inc. | m-PHENYLENEDIAMINE DERIVATIVE |
WO2004004725A2 (en) | 2002-07-09 | 2004-01-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
WO2005028436A2 (en) | 2003-09-17 | 2005-03-31 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Thalidomide analogs as tnf-alpha modulators |
US8952895B2 (en) | 2011-06-03 | 2015-02-10 | Apple Inc. | Motion-based device operations |
GB0324790D0 (en) | 2003-10-24 | 2003-11-26 | Astrazeneca Ab | Amide derivatives |
US20060035893A1 (en) | 2004-08-07 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
EP1953148B1 (de) | 2005-10-28 | 2012-02-29 | Takeda Pharmaceutical Company Limited | Heterocyclische amidverbindung und anwendung davon |
JP5225857B2 (ja) * | 2005-11-14 | 2013-07-03 | ジェネンテック,インコーポレイティド | ヘッジホッグシグナル伝達のビスアミド阻害剤 |
WO2007120669A1 (en) | 2006-04-13 | 2007-10-25 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Tetrahalogenated compounds useful as inhibitors of angiogenesis |
US7671058B2 (en) * | 2006-06-21 | 2010-03-02 | Institute Of Medicinal Molecular Design, Inc. | N-(3,4-disubstituted phenyl) salicylamide derivatives |
WO2008089034A2 (en) * | 2007-01-11 | 2008-07-24 | Kemia, Inc. | Cytokine inhibitors |
EP1992344A1 (de) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 Alpha als therapeutisches Target für Erkrankungen, die mit einer FGFR3- Mutation assoziiert sind |
US8927725B2 (en) | 2011-12-02 | 2015-01-06 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Thio compounds |
CN104326937B (zh) * | 2014-09-03 | 2016-08-24 | 天津市肿瘤研究所 | 抗肿瘤化合物及其医药用途 |
TWI794171B (zh) | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Hdac抑制劑與pd-l1抑制劑之組合治療 |
TWI808055B (zh) | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Hdac 抑制劑與 pd-1 抑制劑之組合治療 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1903899A (en) | 1933-04-18 | Cabboxylic acid abylides oe the benzene sebies and process oe making | ||
US1909960A (en) | 1929-08-06 | 1933-05-23 | Du Pont | Intermediate for azo dyes |
DE2812252A1 (de) | 1978-03-21 | 1979-10-04 | Bayer Ag | 1,2,4-triazol-blockierte polyisocyanate als vernetzer fuer lackbindemittel |
US4524168A (en) | 1981-11-18 | 1985-06-18 | Ciba-Geigy Corporation | Process for the mass coloration of polymers |
US4749729A (en) | 1984-06-21 | 1988-06-07 | American Cyanamid Company | Epoxy resin compositions curable above 160 F. and below 250 F. |
AU2552492A (en) | 1991-08-23 | 1993-03-16 | United States of America as represented by The Secretary Department of Health and Human Services, The | Raf protein kinase therapeutics |
GB9816837D0 (en) | 1998-08-04 | 1998-09-30 | Zeneca Ltd | Amide derivatives |
EP0871444A4 (de) | 1995-08-10 | 1999-01-13 | Merck & Co Inc | 2,5 substituierte aryl pyrrol, dieses enthaltende zusammensetzungen und dessen verwendung |
US6174887B1 (en) * | 1995-08-22 | 2001-01-16 | Japan Tobacco Inc. | Amide compounds and use of the same |
GB9604926D0 (en) | 1996-03-08 | 1996-05-08 | Sandoz Ltd | Organic compounds |
EP0922042A1 (de) | 1996-08-09 | 1999-06-16 | Smithkline Beecham Corporation | Neue piperazin-verbindungen |
GB9623833D0 (en) | 1996-11-16 | 1997-01-08 | Zeneca Ltd | Chemical compound |
IL134723A0 (en) * | 1997-09-23 | 2001-04-30 | Zeneca Ltd | Amide derivatives for the treatment of diseases mediated by cytokines |
GB9809347D0 (en) | 1998-05-05 | 1998-07-01 | Reckitt & Colmann Prod Ltd | Compositions |
PL197181B1 (pl) | 1998-05-15 | 2008-03-31 | Astrazeneca Ab | Pochodna benzamidowa, sposób jej wytwarzania, jej kompozycja farmaceutyczna i jej zastosowanie do wytwarzania leku |
NZ507144A (en) | 1998-05-15 | 2002-10-25 | Astrazeneca Ab | Benzamide derivatives useful for the treatment of diseases mediated by cytokines |
EP1102750A1 (de) | 1998-08-04 | 2001-05-30 | AstraZeneca AB | Amid-derivate verwendbar als inhibitoren der cytokinproduktion |
RU2219171C2 (ru) | 1998-09-25 | 2003-12-20 | Астразенека Аб | Производные амида, способ их получения и фармацевтическая композиция на их основе |
US6593333B1 (en) | 1998-10-01 | 2003-07-15 | Astrazeneca Ab | Substituted anilino-quinazoline (or quinoline) compounds and use thereof |
WO2000055120A1 (en) | 1999-03-17 | 2000-09-21 | Astrazeneca Ab | Amide derivatives |
IL145357A0 (en) | 1999-03-17 | 2002-06-30 | Astrazeneca Ab | Amide derivatives |
GB9924092D0 (en) | 1999-10-13 | 1999-12-15 | Zeneca Ltd | Pyrimidine derivatives |
-
1999
- 1999-05-11 PL PL344185A patent/PL197181B1/pl not_active IP Right Cessation
- 1999-05-11 KR KR1020007012666A patent/KR100628284B1/ko not_active IP Right Cessation
- 1999-05-11 DE DE69921804T patent/DE69921804T2/de not_active Expired - Fee Related
- 1999-05-11 BR BR9910467-9A patent/BR9910467A/pt not_active Application Discontinuation
- 1999-05-11 TR TR2000/03355T patent/TR200003355T2/xx unknown
- 1999-05-11 RU RU2000131610/04A patent/RU2205823C2/ru not_active IP Right Cessation
- 1999-05-11 WO PCT/GB1999/001491 patent/WO1999059960A1/en active IP Right Grant
- 1999-05-11 ES ES99921018T patent/ES2230853T3/es not_active Expired - Lifetime
- 1999-05-11 JP JP2000549579A patent/JP2003505337A/ja not_active Withdrawn
- 1999-05-11 HU HU0102367A patent/HUP0102367A3/hu unknown
- 1999-05-11 NZ NZ507143A patent/NZ507143A/en unknown
- 1999-05-11 CA CA002328699A patent/CA2328699A1/en not_active Abandoned
- 1999-05-11 PT PT99921018T patent/PT1077930E/pt unknown
- 1999-05-11 EP EP99921018A patent/EP1077930B1/de not_active Expired - Lifetime
- 1999-05-11 US US09/674,428 patent/US6465455B1/en not_active Expired - Fee Related
- 1999-05-11 AU AU38392/99A patent/AU748397B2/en not_active Ceased
- 1999-05-11 IL IL13971099A patent/IL139710A/xx not_active IP Right Cessation
- 1999-05-11 SK SK1717-2000A patent/SK286247B6/sk unknown
- 1999-05-11 CN CNB998061441A patent/CN1188389C/zh not_active Expired - Fee Related
- 1999-05-11 ID IDW20002240A patent/ID27285A/id unknown
- 1999-05-11 AT AT99921018T patent/ATE282023T1/de not_active IP Right Cessation
-
2000
- 2000-11-14 NO NO20005766A patent/NO20005766L/no unknown
-
2001
- 2001-06-20 HK HK01104299A patent/HK1033753A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2328699A1 (en) | 1999-11-25 |
DE69921804T2 (de) | 2005-10-27 |
ID27285A (id) | 2001-03-22 |
EP1077930B1 (de) | 2004-11-10 |
PL197181B1 (pl) | 2008-03-31 |
KR100628284B1 (ko) | 2006-09-27 |
CN1359371A (zh) | 2002-07-17 |
ES2230853T3 (es) | 2005-05-01 |
PT1077930E (pt) | 2005-03-31 |
EP1077930A1 (de) | 2001-02-28 |
CN1188389C (zh) | 2005-02-09 |
AU3839299A (en) | 1999-12-06 |
JP2003505337A (ja) | 2003-02-12 |
DE69921804D1 (de) | 2004-12-16 |
NO20005766D0 (no) | 2000-11-14 |
HUP0102367A3 (en) | 2002-11-28 |
WO1999059960A1 (en) | 1999-11-25 |
IL139710A0 (en) | 2002-02-10 |
PL344185A1 (en) | 2001-10-08 |
KR20010043547A (ko) | 2001-05-25 |
HUP0102367A2 (hu) | 2001-10-28 |
SK17172000A3 (sk) | 2001-04-09 |
TR200003355T2 (tr) | 2001-03-21 |
HK1033753A1 (en) | 2001-09-21 |
IL139710A (en) | 2005-07-25 |
ATE282023T1 (de) | 2004-11-15 |
BR9910467A (pt) | 2001-01-09 |
AU748397B2 (en) | 2002-06-06 |
SK286247B6 (sk) | 2008-06-06 |
NZ507143A (en) | 2003-08-29 |
US6465455B1 (en) | 2002-10-15 |
RU2205823C2 (ru) | 2003-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20005766L (no) | Benzamidderivater for behandling av sykdommer mediert av cytokiner | |
DK1017378T3 (da) | Amidderivater til behandling af sygdomme medieret af cytokiner | |
ES2054020T3 (es) | Compuestos biologicamente activos. | |
ES2080900T3 (es) | Derivados piranicos utiles como inhibidores de 5-lipoxigenasa. | |
MY142177A (en) | Benzamide derivatives useful as histone deacetylase inhibitors | |
HUP0102295A2 (hu) | Citokinek által közvetített betegségek kezelésére alkalmas benzamid-származékok | |
NO992336L (no) | Raf-kinase-inhibitorer | |
NO882036L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske ketoner. | |
NO308736B1 (no) | 1,2-difenylpyrrolderivater, farmasøytiske preparater inneholdende disse, og deres anvendelse | |
NO920035D0 (no) | Trifluormetylketon-derivater, og deres fremstilling og anvendelse | |
ES2164109T3 (es) | Derivados de n-(3-piperidinilcarbonil)-beta-alanina como antagonistas de paf. | |
NZ308398A (en) | 2-amino benzoxazin-4-one derivatives and medicaments | |
IL107315A0 (en) | 2-Saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and pharmaceutical compositions containing them | |
ATE88176T1 (de) | 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung. | |
DE69400352D1 (de) | 3- oder 4-Glykosyloxybenzopyranderivat und dieses enthaltende antiallergisches Mittel | |
ATE191643T1 (de) | Substituierte beta-diketone und deren verwendung zur behandlung von entzündlichen eingeweidenerkrankungen | |
ATE212842T1 (de) | Quinoxalin-derivate zur behandlung von tinnitus | |
ATE116287T1 (de) | N-oxyimidsäurederivate. |